Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene

Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene / Tonini, G; Bizzarri, C; Bonfanti, R; Vanelli, M; Cerutti, F; Faleschini, E; Meschi, F; Prisco, F; Ciacco, E; Cappa, M; Torelli, C; Cauvin, V; Tumini, S; Iafusco, D; Barbetti, F. - In: DIABETOLOGIA. - ISSN 0012-186X. - 49:9(2006), pp. 2210-2213. [10.1007/s00125-006-0329-x]